Bank Julius Baer & Co
BCAB icon

Bank Julius Baer & Co’s BioAtla BCAB Stock Holding History

Bank Julius Baer & Co’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,668
Closed -$6.78M – 821
2021
Q1 		$6.78M Buy
+2,668
New +$6.84M 0.05% 178

Other funds holding BCAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Bank Julius Baer & Co's BCAB Position: Q2 2021 in Review

Bank Julius Baer & Co sold out of BioAtla (BCAB) in Q2 2021, closing a stake of 2,668 shares — an estimated $6.78M sold.

Bank Julius Baer & Co first reported a position in BCAB in Q1 2021 and held it in 1 quarter. The position peaked at $6.78M in Q1 2021. 76 funds tracked by Wall St. Rank hold BCAB as of Q2 2021.

  • Bank Julius Baer & Co reported no remaining BioAtla position as of Q2 2021 after selling out during the quarter.
  • Bank Julius Baer & Co sold 2,668 BioAtla shares in Q2 2021, an estimated $6.78M.
  • Bank Julius Baer & Co first reported a position in BioAtla in Q1 2021 and held it in 1 quarter.
  • Bank Julius Baer & Co's BioAtla position peaked at $6.78M in Q1 2021.
  • 76 funds tracked by Wall St. Rank held BioAtla as of Q2 2021.

Based on Bank Julius Baer & Co's 13F filing for Q2 2021, filed 23 Jul 2021.